RPR To Pursue Synercid Pneumonia Indication With Early-2000 Submission
Executive Summary
Rhone-Poulenc Rorer will submit results of a second hospital-acquired pneumonia study to FDA in early-2000 to broaden the indication for its injectable streptogramin antibiotic Synercid.
You may also be interested in...
King Buys Aventis’ Synercid, Tilade, Intal; Will Add 85 Reps To Sales Force
A potential Synercid indication in methicillin-resistant Staphylococcus aureus is one milestone trigger in King's agreement to purchase rights to the antibiotic and two asthma drugs from Aventis
King Buys Aventis’ Synercid, Tilade, Intal; Will Add 85 Reps To Sales Force
A potential Synercid indication in methicillin-resistant Staphylococcus aureus is one milestone trigger in King's agreement to purchase rights to the antibiotic and two asthma drugs from Aventis
Synercid, Zyvox Drug Pricing Discourages Use, IDSA Rep Says
The cost of Aventis' Synercid and Pharmacia's Zyvox discourages use of the drugs for resistant disease pathogens, Infectious Disease Society of America representative Louis Rice, MD, Louis Stokes Cleveland Veterans Affairs Medical Center, told FDA's Anti-Infective Drugs Advisory Committee